Oak Ridge Investments’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Oak Ridge Investments’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-40,694	Closed	-$1.89M	–	164
2018 Q1	$1.89M	Sell	40,694 -28,772	-41%	-$1.05M	0.11%	132
2017 Q4	$2.6M	Sell	69,466 -16,944	-20%	-$740K	0.12%	126
2017 Q3	$4.6M	Sell	86,410 -49,770	-37%	-$2.96M	0.19%	109
2017 Q2	$7.76M	Sell	136,180 -7,811	-5%	-$392K	0.25%	98
2017 Q1	$7.74M	Sell	143,991 -39,036	-21%	-$2.21M	0.26%	91
2016 Q4	$10.4M	Sell	183,027 -28,131	-13%	-$1.7M	0.34%	73
2016 Q3	$13.1M	Sell	211,158 -20,770	-9%	-$1.47M	0.34%	78
2016 Q2	$13.1M	Sell	231,928 -4,273	-2%	-$260K	0.34%	77
2016 Q1	$15.1M	Buy	236,201 +69,034	+41%	+$5.58M	0.38%	77
2015 Q4	$23.5M	Buy	+167,167	New	+$22.7M	0.56%	57

Other funds holding KDNY

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

HMC

Harvard Management Company Boston, Massachusetts $4.26B AUM 5.81% 1-Year Est. Return

Oak Ridge Investments's KDNY Position: Q2 2018 in Review

Oak Ridge Investments sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q2 2018, closing a stake of 40,694 shares — an estimated $1.89M sold.

Oak Ridge Investments first reported a position in KDNY in Q4 2015 and held it in 10 quarters. The position peaked at $23.5M in Q4 2015. 89 funds tracked by Wall St. Rank hold KDNY as of Q2 2018.

Oak Ridge Investments reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
Oak Ridge Investments sold 40,694 Chinook Therapeutics, Inc. Common Stock shares in Q2 2018, an estimated $1.89M.
Oak Ridge Investments first reported a position in Chinook Therapeutics, Inc. Common Stock in Q4 2015 and held it in 10 quarters.
Oak Ridge Investments's Chinook Therapeutics, Inc. Common Stock position peaked at $23.5M in Q4 2015.
89 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q2 2018.

Based on Oak Ridge Investments's 13F filing for Q2 2018, filed 13 Aug 2018.